Drug intelligence / Profile preview

hemiacidrin

Development stage
Approved
Lead developer
United-Guardian
Modality
Small Molecules
Administration
Intravesical, Percutaneous
01

Overview

Renacidin (hemiacidrin) is a sterile, non-pyrogenic irrigation solution developed by United-Guardian. It is a fixed-dose combination of citric acid, gluconolactone (glucono-delta-lactone), and magnesium carbonate. Renacidin is FDA-approved for the dissolution of bladder calculi of the struvite or apatite variety and for the prevention of encrustations of indwelling urethral catheters and cystostomy tubes. It acts as a local urinary acidifying and chelating agent; the citric acid component chelates calcium ions to form soluble complexes, while the acidic pH of the solution solubilizes magnesium ammonium phosphate (struvite) calculi. It is administered locally via intravesical or percutaneous irrigation.

Brand names
Renacidin
Other names
citric acid + gluconolactone + magnesium carbonatecitric acid, glucono-delta-lactone, and magnesium carbonatehemiacidrin

Beyond the preview

Go deeper on hemiacidrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hemiacidrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call